Skip to content

Altimmune ALT Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-42.7%+14.5pp-50.6%+9.3pp-52.6%+20.3pp-55.9%+7.4pp-57.3%-2.8pp
Liquidity
Current ratio29.6×+13.7×18.5×+5.4×17.2×+0.3×20.4×+9.1×15.8×-0.7×
Leverage
Debt-to-equity0.1×+0.1×0.2×+0.1×0.1×+0.1×0.1×+0.1×0.0×
Per Share
Book value per share$2.28+21.3%$2.55+46.7%$2.08+10.6%$1.98-7.9%$1.88-23.0%
Valuation
Market capitalization$558.14M-2.1%$376.68M-26.5%$332.73M-23.8%$583.16M+23.7%$385.07M-46.5%
Price / book-2.0×1.7×-2.5×1.8×-1.5×3.6×+0.5×2.7×-1.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Altimmune's ratios come from?
Every ratio is computed from Altimmune's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.